During the course of our work for the synthesis of inhibitors for b-RAF kinase enzyme which plays a key role in tumorigenesis and cancer progression, 12 it is important to synthesize the dimethylated urea 4 and the monomethylated ureas in order to investigate the mode of action of the synthesized urea derivatives. Herein, we describe a detailed synthesis for pyrimidine urea derivatives and their structure elucidation by FT-NMR and X-ray diffractometer.
The reaction of 3-acetylpyridine with N,N-dimethylformamide dimethylacetal to yield 3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one is reported in a variety of solvents such as toluene 13 and DMF. 14 However, it was most convenient when applied without the use of any solvent, by direct fusion of 3-acetylpyridine with 1.4 equivalents of N,N-dimethylformamide dimethylacetal, where it proceeded smoothly in 4 hours and in a good yield of 82% (Scheme 1). 15 By refluxing 3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one with guanidine hydrochloride in absolute ethanol and in the presence of sodium ethoxide, 4-(pyridin-3-yl)-pyrimidin-2-amine (1) was obtained in a good yield of 73%. The preparation of urea derivatives from the corresponding amines using isocyanates is reported in a variety of solvents such as dioxane, 16 THF 17 and pyridine. 18 In our case, pyridine was used as a solvent, and the reaction of 4-(pyridin-3-yl)pyrimidin-2-amine (1) with 3,5-bis(trifluoromethyl)phenyl isocyanate gave 1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-yl)urea (2) in good yield of 66%. The urea derivative 2 was N-methylated through the reaction of excess (10 equivalents) of methyl iodide in anhydrous THF in the presence of sodium hydride at room temperature under nitrogen atmosphere to obtain two compounds in yield of 22% and 35%, while the unreacted starting compound 2 was recovered in 40%.
By investigating two resulted products, one of them was found to be the dimethylated urea 4 by FT-NMR and FT-IR, while another one was found to be the monomethylated urea 3 by X-ray diffractometer. By repeating the methylation reaction for several times, the same products were obtained in every time, and the only above-mentioned monomethylated derivative 3 was obtained, while another monomethyl regio-isomer, 3-(3,5-bis(trifluoromethyl)phenyl)-3-methyl-1-(4-(pyridin-3-yl)pyrimidin-2-yl)urea could not be obtained. Although we do not precisely know the reason why 3-(3,5-bis(trifluoromethyl)phenyl)-3-methyl-1-(4-(pyridin-3-yl)pyrimidin-2-yl)urea could not be obtained, this might be probably due to the higher stability of N1-anion in compound 2 compared to the N3-anion, since N1-anion is stabilized more by the resonating structure of the pyrimidine Scheme 1. Reaction conditions: a) N,N-dimethylformamide dimethylacetal, fusion, 4 h, 82% yield, b) guanidine HCl, NaOEt, abs. EtOH, reflux, 6 h, 73% yield, c) 3,5-bis(trifluoromethyl)phenyl isocyanate, pyridine, reflux, 24 h, 66% yield, d) CH3I, NaH, THF, rt, 24 h, 22% for compound 3 and 35% yield of compound 4. moiety. The highly electron withdrawing effect exerted by the pyrimidine ring nitrogens could also explain for the higher acidity of N1-proton relative to the other N3-proton.
A yellow platelet crystal of compound 3 having approximate dimensions of 0.40 × 0.30 × 0.05 mm was mounted on a glass fiber. All measurements were made on a Rigaku RAXIS RAPID imaging plate area detector with graphite monochromated Mo-K radiation. The data were collected at a temperature of 25 ± 1 o C to a maximum 2q value of 55.0 o . The structure was solved by direct methods and expanded using Fourier techniques. 19 All calculations were performed using the crystal structure crystallographic software package 20 except for refinement, which was performed using SHELXL-97 (Table 1) . 21 In summary, we prepared some pyrimidine urea derivatives in good yields and in 4 steps and elucidated the structure of the monomethylated urea 3 by X-ray diffractometer. The studies on anticancer activities and mode of action of these synthesized compounds are currently underway.
Experimental Section

1-(3,5-Bis(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)-pyrimidin-2-yl)urea (2).
To a solution of 4-(pyridin-3-yl)pyrimidin-2-amine (1) (1.0 g, 5.81 mmol) in anhydrous pyridine (30 mL) was added 3,5-bis(trifluoromethyl)phenyl isocyanate (1.0 mL, 5.81 mmol) and the resulted mixture was refluxed for 24 hr under N 2 atmosphere. The reaction mixture was evaporated under reduced pressure and the residue was suspended in methanol, filtered by suction filtration, and dried under vacuum to yield the pure product. 
